|
1
|
Nath B and Szabo G: Hypoxia and hypoxia
inducible factors: diverse roles in liver diseases. Hepatology.
55:622–633. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heddleston JM, Li Z, Lathia JD, Bao S,
Hjelmeland AB and Rich JN: Hypoxia inducible factors in cancer stem
cells. Br J Cancer. 102:789–795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mucaj V, Shay JE and Simon MC: Effects of
hypoxia and HIFs on cancer metabolism. Int J Hematol. 95:464–470.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nguyen MP, Lee S and Lee YM: Epigenetic
regulation of hypoxia inducible factor in diseases and
therapeutics. Arch Pharm Res. 36:252–263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adams JM, Difazio LT, Rolandelli RH, Luján
JJ, Haskó G, Csóka B, Selmeczy Z and Németh ZH: HIF-1: a key
mediator in hypoxia. Acta Physiol Hung. 96:19–28. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Semenza GL: Regulation of metabolism by
hypoxia-inducible factor 1. Cold Spring Harb Symp Quant Biol.
76:347–353. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bos R, Zhong H, Hanrahan CF, Mommers EC,
Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ and van
der Wall E: Levels of hypoxia-inducible factor-1α during breast
carcinogenesis. J Natl Cancer Inst. 93:309–314. 2001.
|
|
8
|
Shen M, Kawamoto T, Yan W, Nakamasu K,
Tamagami M, Koyano Y, Noshiro M and Kato Y: Molecular
characterization of the novel basic helix-loop-helix protein DEC1
expressed in differentiated human embryo chondrocytes. Biochem
Biophys Res Commun. 236:294–298. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
St-Pierre B, Flock G, Zacksenhaus E and
Egan SE: Stra13 homodimers repress transcription through class B
E-box elements. J Biol Chem. 277:46544–46551. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zheng Y, Jia Y, Wang Y, Wang M, Li B, Shi
X, Ma X, Xiao D and Sun Y: The hypoxia-regulated transcription
factor DEC1 (Stra13, SHARP-2) and its expression in gastric cancer.
OMICS. 13:301–306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ivanova A, Liao SY, Lerman MI, Ivanov S
and Stanbridge EJ: STRA13 expression and subcellular localisation
in normal and tumour tissues: implications for use as a diagnostic
and differentiation marker. J Med Genet. 42:565–576. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Giatromanolaki A, Koukourakis MI, Sivridis
E, Turley H, Wykoff CC, Gatter KC and Harris AL: DEC1 (STRA13)
protein expression relates to hypoxia-inducible factor 1-alpha and
carbonic anhydrase-9 overexpression in non-small cell lung cancer.
J Pathol. 200:222–228. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jia YF, Xiao DJ, Ma XL, Song YY, Hu R,
Kong Y, Zheng Y, Han SY, Hong RL and Wang YS: Differentiated
embryonic chondrocyte-expressed gene 1 is associated with
hypoxia-inducible factor 1α and Ki67 in human gastric cancer. Diagn
Pathol. 8:372013.PubMed/NCBI
|
|
14
|
Currie MJ, Hanrahan V, Gunningham SP,
Morrin HR, Frampton C, Han C, Robinson BA and Fox SB: Expression of
vascular endothelial growth factor D is associated with hypoxia
inducible factor (HIF-1α) and the HIF-1α target gene DEC1, but not
lymph node metastasis in primary human breast carcinomas. J Clin
Pathol. 57:829–834. 2004.PubMed/NCBI
|
|
15
|
Chen MC, Lee CF, Huang WH and Chou TC:
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of
HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Biochem Pharmacol. 85:1278–1287. 2013.PubMed/NCBI
|
|
16
|
Dery MA, Michaud MD and Richard DE:
Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic
activators. Int J Biochem Cell Biol. 37:535–540. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oommen D and Prise KM: KNK437, abrogates
hypoxia-induced radioresistance by dual targeting of the AKT and
HIF-1α survival pathways. Biochem Biophys Res Commun. 421:538–543.
2012.PubMed/NCBI
|
|
18
|
Turley H, Wykoff CC, Troup S, Watson PH,
Gatter KC and Harris AL: The hypoxia-regulated transcription factor
DEC1 (Stra13, SHARP-2) and its expression in human tissues and
tumours. J Pathol. 203:808–813. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi XH, Zheng Y, Sun Q, Cui J, Liu QH, Qü
F and Wang YS: DEC1 nuclear expression: a marker of differentiation
grade in hepatocellular carcinoma. World J Gastroenterol.
17:2037–2043. 2011. View Article : Google Scholar
|
|
20
|
Wykoff CC, Pugh CW, Maxwell PH, Harris AL
and Ratcliffe PJ: Identification of novel hypoxia dependent and
independent target genes of the von Hippel-Lindau (VHL) tumour
suppressor by mRNA differential expression profiling. Oncogene.
19:6297–6305. 2000. View Article : Google Scholar
|
|
21
|
Zheng Y, Shi X, Wang M, Jia Y, Li B, Zhang
Y, Liu Q and Wang Y: The increased expression of DEC1 gene is
related to HIF-1α protein in gastric cancer cell lines. Mol Biol
Rep. 39:4229–4236. 2012.
|
|
22
|
Chakrabarti J, Turley H, Campo L, Han C,
Harris AL, Gatter KC and Fox SB: The transcription factor DEC1
(stra13, SHARP2) is associated with the hypoxic response and high
tumour grade in human breast cancers. Br J Cancer. 91:954–958.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miyazaki K, Kawamoto T, Tanimoto K,
Nishiyama M, Honda H and Kato Y: Identification of functional
hypoxia response elements in the promoter region of the DEC1 and
DEC2 genes. J Biol Chem. 277:47014–47021. 2002. View Article : Google Scholar : PubMed/NCBI
|
